BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee Y, Li HK, Masaoka A, Sunada S, Hirakawa H, Fujimori A, Nickoloff JA, Okayasu R. The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining. Radiother Oncol 2016;121:162-8. [PMID: 27666928 DOI: 10.1016/j.radonc.2016.08.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Nickoloff JA, Taylor L, Sharma N, Kato TA. Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy. Cancer Drug Resist 2021;4:244-63. [PMID: 34337349 DOI: 10.20517/cdr.2020.89] [Reference Citation Analysis]
2 Zhang J, Si J, Gan L, Zhou R, Guo M, Zhang H. Harnessing the targeting potential of differential radiobiological effects of photon versus particle radiation for cancer treatment. J Cell Physiol 2021;236:1695-711. [PMID: 32691425 DOI: 10.1002/jcp.29960] [Reference Citation Analysis]
3 Sottile ML, Nadin SB. Heat shock proteins and DNA repair mechanisms: an updated overview. Cell Stress Chaperones 2018;23:303-15. [PMID: 28952019 DOI: 10.1007/s12192-017-0843-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 10.6] [Reference Citation Analysis]
4 Kale Ş, Korcum AF, Dündar E, Erin N. HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators. Naunyn Schmiedebergs Arch Pharmacol 2020;393:253-62. [PMID: 31522240 DOI: 10.1007/s00210-019-01725-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Eriksen JG. Radiotherapy in Asia: Making progress step by step. Radiother Oncol 2018;129:1-2. [PMID: 30001934 DOI: 10.1016/j.radonc.2018.06.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Dubrez L, Causse S, Borges Bonan N, Dumétier B, Garrido C. Heat-shock proteins: chaperoning DNA repair. Oncogene 2020;39:516-29. [DOI: 10.1038/s41388-019-1016-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
7 Abad E, Graifer D, Lyakhovich A. DNA damage response and resistance of cancer stem cells. Cancer Lett 2020;474:106-17. [PMID: 31968219 DOI: 10.1016/j.canlet.2020.01.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
8 Deycmar S, Mara E, Kerschbaum-gruber S, Waller V, Georg D, Pruschy M. Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02036-z] [Reference Citation Analysis]
9 Luo W, Ali YF, Liu C, Wang Y, Liu C, Jin X, Zhou G, Liu NA. Particle Therapy for Breast Cancer: Benefits and Challenges. Front Oncol 2021;11:662826. [PMID: 34026640 DOI: 10.3389/fonc.2021.662826] [Reference Citation Analysis]
10 Kabakov AE, Yakimova AO. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. Cancers (Basel) 2021;13:1102. [PMID: 33806538 DOI: 10.3390/cancers13051102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Mehta RK, Pal S, Kondapi K, Sitto M, Dewar C, Devasia T, Schipper MJ, Thomas DG, Basrur V, Pai MP, Morishima Y, Osawa Y, Pratt WB, Lawrence TS, Nyati MK. Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts. Clin Cancer Res 2020;26:5246-57. [PMID: 32718999 DOI: 10.1158/1078-0432.CCR-19-3102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Figueiredo P, Costa M, Pontes O, Baltazar F, Proença F. Adenine Derivatives: Promising Candidates for Breast Cancer Treatment: Adenine Derivatives: Promising Candidates for Breast Cancer Treatment. Eur J Org Chem 2018;2018:3943-56. [DOI: 10.1002/ejoc.201800629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nickoloff JA, Boss MK, Allen CP, LaRue SM. Translational research in radiation-induced DNA damage signaling and repair. Transl Cancer Res 2017;6:S875-91. [PMID: 30574452 DOI: 10.21037/tcr.2017.06.02] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
14 Liu X, Li P, Hirayama R, Niu Y, Liu X, Chen W, Jin X, Zhang P, Ye F, Zhao T, Liu B, Li Q. Genistein sensitizes glioblastoma cells to carbon ions via inhibiting DNA-PKcs phosphorylation and subsequently repressing NHEJ and delaying HR repair pathways. Radiother Oncol 2018;129:84-94. [PMID: 29685705 DOI: 10.1016/j.radonc.2018.04.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
15 Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
16 Nickoloff JA, Jones D, Lee SH, Williamson EA, Hromas R. Drugging the Cancers Addicted to DNA Repair. J Natl Cancer Inst 2017;109. [PMID: 28521333 DOI: 10.1093/jnci/djx059] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 16.6] [Reference Citation Analysis]